Alector (ALEC) Amortizatization of Intangibles (2018 - 2026)
Alector's (ALEC) quarterly Amortizatization of Intangibles came in at $1.0 million in Q2 2026, down 43.12% year-over-year from $1.8 million in Q2 2025, and little changed quarter-over-quarter from $1.0 million in Q1 2026.
Analysis
Alector (ALEC) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Amortizatization of Intangibles for 9 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 43.12% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $4.8 million, a 50.17% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 54.25% from the prior year.
- Amortizatization of Intangibles was $1.0 million for Q2 2026 at Alector, roughly flat from $1.0 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $4.8 million in Q4 2023 and troughed at $670000.0 in Q1 2022.
- A 5-year average of $2.3 million and a median of $1.9 million in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 73.09% in 2022 and surged 568.71% in 2023, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at $719000.0 in 2022, then surged by 568.71% to $4.8 million in 2023, then plunged by 46.36% to $2.6 million in 2024, then plunged by 51.69% to $1.2 million in 2025, then retreated by 19.74% to $1.0 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.0 million (Q2 2026), $1.0 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 678,000.00 |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 4.81 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 3.32 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 719,000.00 |
| Sep 30, 2022 | 696,000.00 |
| Jun 30, 2022 | 673,000.00 |
| Mar 31, 2022 | 670,000.00 |
| Dec 31, 2021 | -3.53 Mn |
| Sep 30, 2021 | 2.59 Mn |